Get startedLog in
    Picture of Centessa Pharmaceuticals logo

    CNTA — Centessa Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Centessa Pharmaceuticals Reports Q3 Financial Results

    Picture of Centessa Pharmaceuticals logoCentessa Pharmaceuticals
    10/11/2022 12:46
    Nov 10 (Reuters) - Centessa Pharmaceuticals PLC
 260y.F :
    * CENTESSA PHARMACEUTICALS REPORTS FINANCIAL RESULTS AND
BUSINESS
HIGHLIGHTS FOR THE THIRD QUARTER OF 2022
    * CENTESSA PHARMACEUTICALS PLC - QTRLY CASH AND CASH
EQUIVALENTS
OF $444.8 MILLION
    * CENTESSA PHARMACEUTICALS PLC - CASH RUNWAY INTO 2026
ENABLES
MULTIPLE CLINICAL READOUTS ACROSS PIPELINE
    * CENTESSA PHARMACEUTICALS PLC - IND SUBMISSION FOR LB101, A
CONDITIONALLY TETRAVALENT PD-L1XCD47 BISPECIFIC MONOCLONAL
ANTIBODY, ON TRACK FOR LATE 2022
    * CENTESSA PHARMACEUTICALS PLC - QTRLY LOSS PER SHARE $0.57

Source text for Eikon:  ID:nGNX5jzLBh 
Further company coverage:  260y.F 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Centessa Pharmaceuticals

    See all news